Cargando…

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era

In the last ten years, liquid biopsy has been slowly joining the traditional invasive techniques for the diagnosis and monitoring of tumors. Liquid biopsies allow easy repeated sampling of blood, reflect the tumor scenario, and make personalized therapy real for the patient. Liquid biopsies isolate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmieri, Maria, Frullanti, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844315/ https://www.ncbi.nlm.nih.gov/pubmed/36649045 http://dx.doi.org/10.3390/medsci11010008

Ejemplares similares

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
por: Palmieri, Maria, et al.
Publicado: (2022)

Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report
por: Fadda, Giovanni M., et al.
Publicado: (2022)

Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016)

Future directions and management of liquid biopsy in non-small cell lung cancer
por: Cossu, Alessia Maria, et al.
Publicado: (2020)

Update on liquid biopsy in clinical management of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Liquid biopsy in lung cancer management
por: Irofei Zamfir, Maria-Anca, et al.
Publicado: (2022)

Liquid Biopsies in Colorectal Liver Metastases: Towards the Era of Precision Oncologic Surgery
por: Tsilimigras, Diamantis I., et al.
Publicado: (2022)

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022)

The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients
por: Roldan Ruiz, Jonnathan, et al.
Publicado: (2023)

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
por: Nacchio, Mariantonia, et al.
Publicado: (2020)

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance
por: Schwartzberg, Lee S., et al.
Publicado: (2020)

The Role of Serial Liquid Biopsy in the Management of Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Sama, Srikar, et al.
Publicado: (2022)

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
por: Rijavec, Erika, et al.
Publicado: (2019)

Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation
por: Palmieri, Maria, et al.
Publicado: (2020)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
por: Casula, Milena, et al.
Publicado: (2023)

Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy
por: Lu, Jun, et al.
Publicado: (2018)

Clinical Perspective and Translational Oncology of Liquid Biopsy
por: Fernández-Lázaro, Diego, et al.
Publicado: (2020)

Biopsy and Mutation Detection Strategies in Non-Small Cell Lung Cancer
por: Jung, Chi Young
Publicado: (2013)

The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
por: Zhang, Yi-Chen, et al.
Publicado: (2017)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019)

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
por: Akhoundova, D., et al.
Publicado: (2020)

Current status and future perspectives of liquid biopsy in non-small cell lung cancer
por: Chang, Sunhee, et al.
Publicado: (2020)

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
por: Nagasaka, Misako, et al.
Publicado: (2021)

Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
por: Bonanno, Laura, et al.
Publicado: (2022)

The Overview of Perspectives of Clinical Application of Liquid Biopsy in Non-Small-Cell Lung Cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2022)

Liquid Biopsy for Guiding Treatment Decisions in Advanced Non–Small Cell Lung Cancer
por: Suk, Gretchen
Publicado: (2022)

Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience
por: Ulivi, Paola, et al.
Publicado: (2021)

Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds
por: Walker, Paul R.
Publicado: (2023)

Liquid biopsies in pediatric oncology: opportunities and obstacles
por: Sundby, R. Taylor, et al.
Publicado: (2022)

The coming of age of liquid biopsy in neuro-oncology
por: Berzero, Giulia, et al.
Publicado: (2023)

Liquid Biopsy in the OMICS Era of Tumor Medicine
por: Jiang, Yi, et al.
Publicado: (2018)

Commentary: Potential Links between Hepadnavirus and Bornavirus Sequences in the Host Genome and Cancer
por: Cetta, Francesco, et al.
Publicado: (2018)

Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy
por: von Baumgarten, Louisa, et al.
Publicado: (2020)

Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021)

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
por: Calabrese, Fiorella, et al.
Publicado: (2019)

Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
por: Huang, Lanxiang, et al.
Publicado: (2021)

The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer
por: Ezeife, Doreen A., et al.
Publicado: (2022)

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
por: Shen, Haifeng, et al.
Publicado: (2022)

Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer
por: Brockley, Liam J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h4t9c3almei3segsiejk4usbfu